HOXB13 immunostaining was linked to advanced pathological tumor stage, high Gleason grade, and lymph node metastasis (p < 0.0001 each) in subsets of both ERG-negative (Supplementary Table 2) and ERG-positive cancers (Supplementary Table 3). Here, HOXB13 is linked to cancer.